摘要：SummaryMost triacylglycerol-lowering fibrates have been developed in the 1960s–1980s before their molecular target, peroxisome proliferator-activated receptor alpha (PPARα), was identified. Twenty-one ligand-bound PPARα structures have been deposited in the Protein Data Bank since 2001; however, binding modes of fibrates and physiological ligands remain unknown. Here we show thirty-four X-ray crystallographic structures of the PPARα ligand-binding domain, which are composed of a “Center” and four “Arm” regions, in complexes with five endogenous fatty acids, six fibrates in clinical use, and six synthetic PPARα agonists. High-resolution structural analyses, in combination with coactivator recruitment and thermostability assays, demonstrate that stearic and palmitic acids are presumably physiological ligands; coordination to Arm III is important for high PPARα potency/selectivity of pemafibrate and GW7647; and agonistic activities of four fibrates are enhanced by the partial agonist GW9662. These results renew our understanding of PPARα ligand recognition and contribute to the molecular design of next-generation PPAR-targeted drugs.Graphical AbstractDisplay OmittedHighlights•X-ray crystallography reveals 34 high-resolution human PPARα-ligand structures•Stearic acid and palmitic acid are presumably physiological PPARα ligands•Coordination to Arm III domain is important for high PPARα potency/selectivity•Agonistic activities of four fibrates are enhanced by the partial agonist GW9662Biochemistry; Molecular Physiology; Structural Biology; Protein Structure Aspects
